A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-0843
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer ; volume:82 ; number:3 ; day:20 ; month:6 ; year:2018 ; pages:407-418 ; date:9.2018
Cancer chemotherapy and pharmacology ; 82, Heft 3 (20.6.2018), 407-418, 9.2018

Creator
Patnaik, Amita
Contributor
Gordon, Michael
Tsai, Frank
Papadopoulous, Kyri
Rasco, Drew
Beeram, S. Muralidhar
Fu, Siqing
Janku, Filip
Hynes, Scott M.
Gundala, Sushma R.
Willard, Melinda D.
Zhang, Wei
Lin, Aimee Bence
Hong, David
SpringerLink (Online service)

DOI
10.1007/s00280-018-3623-7
URN
urn:nbn:de:101:1-2018092811004889594916
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Patnaik, Amita
  • Gordon, Michael
  • Tsai, Frank
  • Papadopoulous, Kyri
  • Rasco, Drew
  • Beeram, S. Muralidhar
  • Fu, Siqing
  • Janku, Filip
  • Hynes, Scott M.
  • Gundala, Sushma R.
  • Willard, Melinda D.
  • Zhang, Wei
  • Lin, Aimee Bence
  • Hong, David
  • SpringerLink (Online service)

Other Objects (12)